Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus

Clinical trial NCT01764594 · COMPLETED

Trial details

NCT number: NCT01764594
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune System Diseases Autoimmune Diseases Lupus Erythematosus, Systemic Skin and Connective Tissue Diseases Connective Tissue Disease

Start date: 2013-01-01
Primary completion: 2014-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.